Pentoxifylline
- Strength
- 400 mg/1
- Form
- Tablet, Extended Release
- Class
- Blood Viscosity Reducer
ANI Pharmaceuticals, Inc.
Listed by Rising Pharma Holdings, Inc.
| Dosage form | Tablet, Extended Release |
|---|---|
| Route | Oral |
| Drug class | Blood Viscosity Reducer |
| Approval route | ANDA — approved generic |
| NDC code | 16571-856 |
| FDA application | ANDA074425 |
| RxNorm concept | 312301 |
| Package sizes listed | 5 |
| Marketed since | June 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ANI Pharmaceuticals, Inc.
Apotex Corp.
Bryant Ranch Prepack
Major Pharmaceuticals
Bryant Ranch Prepack
NCS HealthCare of KY, LLC dba Vangard Labs
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.